---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-027936"
form_type: "8-K"
ticker: "SMTI"
cik: "0000714256"
company_name: "Sanara MedTech Inc."
filed_at: "2026-06-09T20:15:25+00:00"
generated_at: "2026-06-09T20:16:18.967112+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Sanara MedTech annual meeting results: all proposals approved; board adopts triennial advisory vote on exec comp

## Summary
- All nine director nominees elected, with each receiving >5M for votes (including Yon, Nixon, DeSutter).
- Weaver and Tidwell ratified as auditor for FY2026: 6,696,035 for, 2,198 against.
- Advisory say-on-pay approved: 5,280,546 for (98.9% of votes cast).
- Frequency vote favors three years (4,296,133); board sets triennial advisory vote on exec comp, next vote in 2029.

## SEC filing metadata
- accession: 0001493152-26-027936
- form_type: 8-K
- ticker: SMTI
- cik: 0000714256
- company_name: Sanara MedTech Inc.
- filed_at: 2026-06-09T20:15:25+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/714256/000149315226027936/0001493152-26-027936-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/714256/000149315226027936/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-027936
- JSON: https://secwatch.observer/filing/0001493152-26-027936.json
- Plain text: https://secwatch.observer/filing/0001493152-26-027936.txt

## Key facts
- Shareholder Votes
  Sanara MedTech Inc. shareholders approved Ratification of the appointment of Weaver and Tidwell, L.L.P. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-06-04 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: Proposal 2 : Ratification of the appointment of Weaver and Tidwell, L.L.P. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315226027936/0001493152-26-027936-index.htm
- Shareholder Votes
  Sanara MedTech Inc. shareholders approved Advisory approval of the compensation of the Company’s named executive officers at the 2026-06-04 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: Proposal 3: Approval, on an advisory basis, of the compensation of the Company’s named executive officers.
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315226027936/0001493152-26-027936-index.htm
- Shareholder Votes
  Sanara MedTech Inc. shareholders approved Advisory vote on the frequency of future advisory votes on named executive officer compensation at the 2026-06-04 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: Proposal 4 : Approval, on an advisory basis, of the frequency of future advisory votes on named executive officer compensation.
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315226027936/0001493152-26-027936-index.htm
- Shareholder Votes
  Sanara MedTech Inc. shareholders approved Election of nine directors to serve for a one-year term until 2027 annual meeting at the 2026-06-04 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-06-04
  source text: Proposal 1 : Election of (i) Seth D. Yon, (ii) Ronald T. Nixon, (iii) Robert A. DeSutter, (iv) Roszell Mack III, (v) Eric D. Major, (vi) Keith G. Myers, (vii) Sara N. Ortwein, (viii) Ann Beal Salamone and (ix) Eric D. Tanzberger to the Board of Directors of the Company, each to serve for a one-year term until the annual meeting of shareholders to be held in 2027 and until his or her successor is elected and qualified.
  evidence_url: https://www.sec.gov/Archives/edgar/data/714256/000149315226027936/0001493152-26-027936-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.